Stocks · Healthcare · Medical - Healthcare Information Services
Doximity, Inc. DOCS
$27.93 -2.00% Close, Oct 2, 2026 · NYSE · Market cap $5.22B
High qualityInexpensive vs sector
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to 29.6% from 40.1% a year earlier.
- Over the past year the stock returned -60.5%, behind the S&P 500 by 75.5 percentage points.
- The stock is 62% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 46%
- EPS growth (TTM, YoY)Bottom 35%
- FCF growth (TTM, YoY)Bottom 45%
- Revenue growth, 3-year CAGRTop 38%
- Revenue growth accelerationBottom 36%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 8%
- Gross marginTop 21%
- Operating marginTop 7%
- Cash conversion (OCF / net income)Top 36%
- Accruals (lower is better)Top 26%
- Net debt / EBITDA (lower is better)Top 19%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 18%
- Free-cash-flow yieldTop 16%
- EBITDA / enterprise valueTop 23%
- Sales / enterprise valueBottom 37%
- P/E vs own 5-year history (lower is better)Top 30%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 3%
- 6-month returnTop 37%
- 1-year return vs S&P 500Bottom 6%
- Distance from 52-week highBottom 14%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 49%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 6%
- Upside to consensus price targetBottom 9%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 24%
- Maximum drawdown, 3 yearsBottom 36%
- Beta vs S&P 500 (lower is better)Bottom 21%
- Net debt / EBITDA (lower is better)Top 19%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 13.1% | 11.2% | ↓ |
| EPS growth (YoY) | -10.8% | -27.4% | ↓ |
| Gross margin | 90.1% | 88.1% | ↓ |
| Operating margin | 40.1% | 29.6% | ↓ |
| FCF margin | 48.7% | 45.7% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 11.2% | 13.1% | ↓ | Top 46% |
| EPS growth (TTM, YoY) | -27.4% | -10.8% | ↓ | Bottom 35% |
| Gross margin | 88.1% | 90.1% | ↓ | Top 21% |
| Operating margin | 29.6% | 40.1% | ↓ | Top 7% |
| Net margin | 25.5% | 39.9% | ↓ | — |
| Free-cash-flow margin | 45.7% | 48.7% | ↓ | — |
| Return on invested capital | 15.3% | — | Top 8% | |
| Revenue growth, 3-year CAGR | 15.5% | — | Top 38% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.83×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -12.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 20.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +14.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -1.08×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 7.40%
- Shareholder yield
- 7.40%
- Share count change, 1 year
- -5.0%
- Share count change, 3-year CAGR
- -3.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +3.0%
- Average 2-day reaction, last 8
- -2.8%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $27.00
- Target vs current price
- -3.3%
- Analysts with a rating
- 24
- Share rating Buy or Strong Buy
- 38%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -4.3% | -4.5% | +15.5% | +21.7% | — |
| May 13, 2026 | -7.1% | -11.6% | -27.2% | -23.5% | +3.6% |
| Feb 5, 2026 | +4.5% | -5.5% | -26.4% | -26.0% | -29.1% |
| Nov 6, 2025 | +18.8% | -2.2% | -20.4% | -19.8% | -45.5% |
| Aug 7, 2025 | +19.4% | +0.7% | +10.1% | +17.9% | +13.2% |
| May 15, 2025 | +39.9% | -1.8% | -14.7% | -4.3% | +3.9% |
| Feb 6, 2025 | +45.2% | +0.2% | +29.3% | +13.5% | +2.0% |
| Nov 7, 2024 | +20.0% | +2.5% | +24.8% | +30.6% | +37.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.29 | $0.30 | -4.3% | $156.6M |
| May 13, 2026 | $0.26 | $0.28 | -7.1% | $145.4M |
| Feb 5, 2026 | $0.46 | $0.44 | +4.5% | $185.1M |
| Nov 6, 2025 | $0.45 | $0.38 | +18.8% | $168.5M |
| Aug 7, 2025 | $0.36 | $0.30 | +19.4% | $145.9M |
| May 15, 2025 | $0.38 | $0.27 | +39.9% | $138.3M |
| Feb 6, 2025 | $0.45 | $0.31 | +45.2% | $168.6M |
| Nov 7, 2024 | $0.30 | $0.25 | +20.0% | $136.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 32.9× | 49.9× | 19th | Top 18% |
| P/E (forward) | 20.7× | — | — | — |
| EV / EBITDA | 20.3× | — | — | Top 23% |
| EV / Sales | 7.57× | — | — | Bottom 37% |
| Free-cash-flow yield | 5.73% | — | — | Top 16% |
| Earnings yield | 3.04% | — | — | Top 18% |
P/E over the past five years
Range 19.4× – 227.7× since Sep 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -60.5%
- Earnings per share growth (TTM)
- -27.4%
- Change in P/E multiple
- -51.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 40
- Days above the 200-day average
- 3
- 50-day average slope (20 days)
- +8.2%
- 200-day average slope (20 days)
- -7.5%
- Distance from 50-day average
- +11.4%
- Distance from 200-day average
- +4.3%
- RSI (14)
- 61.1
- Relative volume
- 0.90×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 73.9%
- Volatility vs own 5-year history
- 66th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.76
- Correlation with S&P 500
- 0.40
- Current drawdown from 1-year high
- -62.0%
- Maximum drawdown, 3 years
- -78.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 10, 2021 | May 14, 2026 | -82.3% | 1173 days | Not yet recovered |
| Jul 26, 2021 | Aug 6, 2021 | -21.3% | 9 days | 3 days (Aug 11, 2021) |
| Jun 28, 2021 | Jul 6, 2021 | -19.8% | 5 days | 12 days (Jul 22, 2021) |
| Aug 25, 2021 | Aug 26, 2021 | -12.8% | 1 days | 5 days (Sep 2, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $5.22B
- P/E (TTM)
- 32.9
- EPS, diluted (TTM)
- $0.85
- Revenue (TTM)
- $655.6M
- 52-week range
- $17.15 – $74.33
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $343.5M | $419.1M | $475.4M | $570.4M | $644.9M |
| Gross profit | $303.8M | $365.6M | $424.8M | $514.5M | $574.5M |
| Operating income | $113.5M | $125.1M | $163.9M | $227.8M | $214.9M |
| Net income | $154.8M | $112.8M | $147.6M | $223.2M | $196.1M |
| EPS (diluted) | $0.70 | $0.53 | $0.72 | $1.11 | $0.98 |
| Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $136.8M | $168.6M | $138.3M | $145.9M | $168.5M | $185.1M | $145.4M | $156.6M |
| Net income | $44.2M | $75.2M | $62.5M | $53.3M | $62.1M | $61.6M | $19.1M | $24.3M |
| EPS (diluted) | $0.22 | $0.37 | $0.31 | $0.27 | $0.31 | $0.31 | $0.10 | $0.13 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | $126.6M | $179.6M | $184.1M | $273.3M | $326.5M |
| Capital expenditure | -$5.7M | -$6.2M | -$5.8M | -$6.5M | -$9.0M |
| Free cash flow | $120.9M | $173.4M | $178.3M | $266.7M | $317.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $551.2M | -$85.3M | -$280.7M | -$97.0M | -$418.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $687.8M
- Total assets
- $1.08B
- Total liabilities
- $167.8M
- Total debt
- $9.7M
- Net debt
- -$263.9M
- Shareholders’ equity
- $916.1M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 12,382,007
- Days to cover
- 4.92
- Change vs previous report
- -11.8%
FINRA short interest, settlement date Sep 15, 2026.